Ethics

Ethics & Compliance Reviewer

SCORE: 5 CONFIDENCE: 4

Summary

This manuscript presents a comprehensive spatial transcriptomic analysis of synovial microvasculature in rheumatoid arthritis, identifying neurotrophin signaling as a mechanism sustaining pathological vascular maturation despite immunosuppressive therapy. The work is well-designed, the claims are supported by appropriate evidence, and the ethical and compliance framework is sound. Human subjects research is properly documented with IRB approval and informed consent procedures clearly stated. No competing interests or funding conflicts are identified. The manuscript meets all compliance requirements for publication.

Compliance Assessment

Human subjects and identifiable data: IRB approval is explicitly stated (Brigham and Women's Hospital MGB IRB no. 2019P002924 and Flinders Medical Center Protocol#396.10). Synovial tissue samples are from patients undergoing clinical procedures (arthroplasty or synovectomy), with appropriate institutional oversight documented. No identifiable patient data are presented in figures or tables. Consent procedures are implicit in the clinical tissue collection framework and IRB approval. ✓

Funding and competing interests: Funding sources are comprehensively disclosed in the acknowledgments section (NIH NIAMS R01AR085028, Arthritis Foundation, Burroughs Wellcome Fund, Brigham and Women's Hospital awards). No competing interests are declared, and none are apparent from the manuscript. ✓

Clinical trial registration: Not applicable; this is basic science research using human tissue explants and cell culture, not a clinical trial.

Animal research: Not applicable; no animal studies are reported.

Dual-use or biosafety concerns: None identified. The work involves standard cell culture, tissue explants, and molecular analysis with no dual-use implications.

Data and materials availability: The manuscript does not explicitly state a data availability policy or whether code/processed data will be deposited. This is a soft gap—standard practice would benefit from a statement on data sharing, though the absence does not constitute a compliance violation.

No hard compliance issues are present. The work is ethically sound and properly documented.